Oregon Public Employees Retirement Fund’s Vanda Pharmaceuticals VNDA Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,884	Closed	-$118K	–	1695
2023 Q2	$118K	Sell	17,884 -800	-4%	-$5.13K	﹤0.01%	1665
2023 Q1	$127K	Sell	18,684 -50	-0.3%	-$352	﹤0.01%	1655
2022 Q4	$138K	Buy	18,734 +204	+1%	+$1.99K	﹤0.01%	1644
2022 Q3	$183K	Hold	18,530	–	–	﹤0.01%	1579
2022 Q2	$202K	Sell	18,530 -2,140	-10%	-$22.2K	﹤0.01%	1408
2022 Q1	$234K	Sell	20,670 -500	-2%	-$6.57K	﹤0.01%	1599
2021 Q4	$332K	Sell	21,170 -1,000	-5%	-$17.4K	﹤0.01%	1415
2021 Q3	$380K	Sell	22,170 -100	-0.4%	-$1.75K	﹤0.01%	1383
2021 Q2	$479K	Hold	22,270	–	–	0.01%	1322
2021 Q1	$334K	Buy	22,270 +400	+2%	+$6.47K	﹤0.01%	1439
2020 Q4	$287K	Sell	21,870 -344	-2%	-$4.14K	﹤0.01%	1422
2020 Q3	$215K	Buy	22,214 +1,100	+5%	+$11.8K	﹤0.01%	1396
2020 Q2	$242K	Hold	21,114	–	–	﹤0.01%	1350
2020 Q1	$219K	Hold	21,114	–	–	﹤0.01%	1317
2019 Q4	$346K	Hold	21,114	–	–	﹤0.01%	1333
2019 Q3	$280K	Buy	21,114 +400	+2%	+$5.58K	﹤0.01%	1444
2019 Q2	$292K	Buy	20,714 +400	+2%	+$6.37K	﹤0.01%	1440
2019 Q1	$374K	Buy	20,314 +367	+2%	+$8.36K	0.01%	1360
2018 Q4	$521K	Buy	+19,947	New	+$469K	0.01%	1199

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Oregon Public Employees Retirement Fund's VNDA Position: Q3 2023 in Review

Oregon Public Employees Retirement Fund sold out of Vanda Pharmaceuticals (VNDA) in Q3 2023, closing a stake of 17,884 shares — an estimated $118K sold.

Oregon Public Employees Retirement Fund first reported a position in VNDA in Q4 2018 and held it in 19 quarters. The position peaked at $521K in Q4 2018. 179 funds tracked by Wall St. Rank hold VNDA as of Q3 2023.

Oregon Public Employees Retirement Fund reported no remaining Vanda Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Oregon Public Employees Retirement Fund sold 17,884 Vanda Pharmaceuticals shares in Q3 2023, an estimated $118K.
Oregon Public Employees Retirement Fund first reported a position in Vanda Pharmaceuticals in Q4 2018 and held it in 19 quarters.
Oregon Public Employees Retirement Fund's Vanda Pharmaceuticals position peaked at $521K in Q4 2018.
179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2023.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q3 2023, filed 27 Oct 2023.